Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-041719
Filing Date
2012-07-23
Accepted
2012-07-23 17:02:13
Documents
1
Period of Report
2012-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd351489.html 4  
1 FORM 4 rrd351489.xml 4 3746
  Complete submission text file 0001181431-12-041719.txt   5284
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE, SUITE 210 RALEIGH NC 27607
Business Address
Poole William (Reporting) CIK: 0001326017 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 12974856